Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
LDLR- |
RCV000237872 | SCV000295751 | likely benign | Hypercholesterolemia, familial, 1 | 2016-03-25 | criteria provided, single submitter | literature only | |
Cardiovascular Research Group, |
RCV000237872 | SCV000322986 | uncertain significance | Hypercholesterolemia, familial, 1 | 2016-03-01 | criteria provided, single submitter | research | 0/95 non-FH individuals |
Color Diagnostics, |
RCV000775080 | SCV000909184 | likely benign | Familial hypercholesterolemia | 2017-06-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000775080 | SCV001732000 | benign | Familial hypercholesterolemia | 2024-01-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002411106 | SCV002720564 | benign | Cardiovascular phenotype | 2021-12-04 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV000237872 | SCV004818465 | likely benign | Hypercholesterolemia, familial, 1 | 2023-12-18 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004745309 | SCV005360127 | likely benign | LDLR-related disorder | 2024-08-01 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |